The Effect of Rho-Associated Protein Kinase Inhibitor on Monkey Schlemm's Canal Endothelial Cells
Investigative Ophthalmology & Visual Science2012Vol. 53(6), pp. 3092–3092
Citations Over TimeTop 10% of 2012 papers
Takanori Kameda, Toshihiro Inoue, Masaru Inatani, Tomokazu Fujimoto, Megumi Honjo, N. Kasaoka, Miyuki Inoue-Mochita, Nagahisa Yoshimura, Hidenobu Tanihara
Abstract
Y-27632 increased the permeability of the SCE-cell monolayer in association with disruption of the tight junction, F-actin depolymerization, and changes in various cell functions, including calcium transfer.
Related Papers
- → Pharmacological Characterization of SAR407899, a Novel Rho-Kinase Inhibitor(2009)86 cited
- → Long-Term Treatment With a Specific Rho-Kinase Inhibitor Suppresses Cardiac Allograft Vasculopathy in Mice(2003)86 cited
- → Rho-Kinase Inhibition Reduces Myofibroblast Differentiation and Proliferation of Scleral Fibroblasts Induced by Transforming Growth Factor β and Experimental Glaucoma(2018)53 cited
- → Molecular Mechanisms and Therapeutic Strategies of Chronic Renal Injury: Renoprotective Effect of Rho-Kinase Inhibitor in Hypertensive Glomerulosclerosis(2006)43 cited
- Long-Term Treatment With a Specific Rho-Kinase Inhibitor Suppresses Cardiac Allograft Vasculopathy in Mice(2004)